| Literature DB >> 30577773 |
Rolf H H Groenwold1,2,3, Inbal Shofty4, Milica Miočević4, Maarten van Smeden5,6,7, Irene Klugkist4,8.
Abstract
BACKGROUND: Observational studies of medical interventions or risk factors are potentially biased by unmeasured confounding. In this paper we propose a Bayesian approach by defining an informative prior for the confounder-outcome relation, to reduce bias due to unmeasured confounding. This approach was motivated by the phenomenon that the presence of unmeasured confounding may be reflected in observed confounder-outcome relations being unexpected in terms of direction or magnitude.Entities:
Keywords: Bayesian statistics; Bias; Confounding; Sensitivity analysis
Mesh:
Substances:
Year: 2018 PMID: 30577773 PMCID: PMC6303957 DOI: 10.1186/s12874-018-0634-3
Source DB: PubMed Journal: BMC Med Res Methodol ISSN: 1471-2288 Impact factor: 4.615
Fig. 1Structural relations between an exposure (X), an outcome (Y), and two confounders (Z and U) of the exposure-outcome relation. See main text for details and explanation
Results of the simulation study of different methods to control for confounding
| Scenario | Parameter settings | Frequentist model | Bayesian model | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Unadjusted | Adjusted for Z | Adjusted for Z, τ = 1000 | Adjusted for Z, τ = 10 | |||||||||||||
|
|
|
|
| Bias | SD | MSE | Bias | SD | MSE | Bias | SD | MSE | Bias | SD | MSE | |
| 1 | 0 | 1 | 0 | 0 | 0.50 | 0.027 | 0.25 | 0.00 | 0.034 | 0.0011 | 0.00 | 0.025 | 0.0006 | 0.00 | 0.033 | 0.0011 |
| 2 | 1 | 1 | 0 | 0 | 0.67 | 0.027 | 0.45 | 0.00 | 0.035 | 0.0012 | 0.00 | 0.022 | 0.0005 | 0.00 | 0.034 | 0.0012 |
| 3 | 0 | 1 | 1 | 0 | 0.33 | 0.024 | 0.11 | 0.00 | 0.024 | 0.0006 | 0.00 | 0.021 | 0.0004 | 0.00 | 0.024 | 0.0006 |
| 4 | 1 | 1 | 1 | 0 | 0.50 | 0.016 | 0.25 | 0.00 | 0.031 | 0.0009 | 0.00 | 0.017 | 0.0003 | 0.00 | 0.030 | 0.0009 |
| 5 | 0 | 1 | 2 | 0 | 0.17 | 0.017 | 0.029 | 0.00 | 0.014 | 0.0002 | 0.00 | 0.013 | 0.0002 | 0.00 | 0.014 | 0.0002 |
| 6 | 1 | 1 | 2 | 0 | 0.36 | 0.012 | 0.13 | 0.00 | 0.020 | 0.0004 | 0.00 | 0.011 | 0.0001 | 0.00 | 0.020 | 0.0004 |
| 7 | 0 | 1 | 0 | 1 | 0.50 | 0.034 | 0.25 | 0.00 | 0.043 | 0.0019 | 0.00 | 0.032 | 0.001 | 0.00 | 0.043 | 0.0018 |
| 8 | 1 | 1 | 0 | 1 | 1.00 | 0.036 | 1.00 | 0.00 | 0.034 | 0.0012 | 0.23 | 0.026 | 0.055 | 0.00 | 0.034 | 0.0012 |
| 9 | 0 | 1 | 1 | 1 | 0.67 | 0.023 | 0.45 | 0.50 | 0.029 | 0.25 | 0.38 | 0.024 | 0.15 | 0.50 | 0.029 | 0.25 |
| 10 | 1 | 1 | 1 | 1 | 0.83 | 0.018 | 0.69 | 0.33 | 0.028 | 0.11 | 0.33 | 0.017 | 0.11 | 0.33 | 0.028 | 0.11 |
| 11 | 0 | 1 | 2 | 1 | 0.50 | 0.016 | 0.25 | 0.40 | 0.016 | 0.16 | 0.36 | 0.015 | 0.13 | 0.40 | 0.015 | 0.16 |
| 12 | 1 | 1 | 2 | 1 | 0.64 | 0.011 | 0.41 | 0.33 | 0.018 | 0.11 | 0.29 | 0.010 | 0.085 | 0.33 | 0.017 | 0.11 |
| 13 | 0 | 1 | 0 | 2 | 0.50 | 0.049 | 0.25 | −0.01 | 0.066 | 0.0044 | 0.00 | 0.047 | 0.0022 | −0.01 | 0.063 | 0.004 |
| 14 | 1 | 1 | 0 | 2 | 1.34 | 0.045 | 1.79 | 0.01 | 0.057 | 0.0033 | 0.57 | 0.036 | 0.32 | 0.034 | 0.055 | 0.0042 |
| 15 | 0 | 1 | 1 | 2 | 1. 01 | 0.032 | 1.00 | 1.00 | 0.037 | 1.00 | 0.72 | 0.035 | 0.52 | 0.99 | 0.037 | 0.97 |
| 16 | 1 | 1 | 1 | 2 | 1.17 | 0.024 | 1.36 | 0.67 | 0.038 | 0.45 | 0.67 | 0.021 | 0.45 | 0.67 | 0.037 | 0.45 |
| 17 | 0 | 1 | 2 | 2 | 0.83 | 0.019 | 0.70 | 0.80 | 0.020 | 0.64 | 0.71 | 0.019 | 0.50 | 0.80 | 0.020 | 0.64 |
| 18 | 1 | 1 | 2 | 2 | 0.91 | 0.013 | 0.83 | 0.67 | 0.023 | 0.45 | 0.58 | 0.012 | 0.33 | 0.66 | 0.022 | 0.44 |
Bias refers to the bias in the estimator of the relation between X and Y, compared to the true X-Y relation (βyx = 0). τ indicates the precision of the prior distribution of the Z-Y relation in the Bayesian model and is proportional to the sample size of each generated data set (n = 1000). Abbreviations: SD – standard deviation of the empirical distributions of the parameter estimates; MSE – mean squared error of the parameter estimates. See text for details on simulation study
Estimated effect of LDL cholesterol levels on systolic blood pressure, using different methods to deal with unmeasured confounding
| Referencea | Frequentist analysis | Bayesian analysis - 1 | Bayesian analysis - 2 | |
|---|---|---|---|---|
| Prior for relation BMI-SBPb | – | – | N(μ = 0.32, τ = 1000) | N(μ =0.77, τ = 100) |
| Estimated effect of LDL on SBPb | 1.24 (0.53) | 1.03 (0.53) | 1.06 (0.53) | 1.05 (0.54) |
| Estimated effect of BMI on SBPb | 0.32 (0.15) | 0.44 (0.14) | 0.33 (0.03) | 0.66 (0.08) |
Figures represent estimates (SE) of the estimated relations, or the mean (standard deviation) of the posterior distributions. In all analyses (except for the reference), BMI was considered a measured confounder of the LDL-SBP relation, while blood glucose level was considered unmeasured confounder. Bayesian analysis 1 and Bayesian analysis 2 differ in the mean and precision of the prior distribution of the relation between BMI and SBP
aThe reference is based on the full model, i.e., is adjusted for BMI and blood glucose levels
bSBP was measured in mmHg, LDL in mmol/l, and BMI in kg/m2